Form D · Biotechnology
iOncologi, Inc.
Gainesville, FL · CIK 0001750036
Offering snapshot reported May 23, 2025 · SEC filing
- Reported sold
- $250K Offering amount: $12M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 8, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 23, 2025 | Initial | $250,000 | No comparison | 3 | SEC filing |
| Mar 5, 2025 | Initial | $3,000,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-547039
Source: Form D, filed May 23, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mona Flores | Director |
| Catherine Flores | Director |
| Paolo Fundaro | Director |
| Peter Kash | Director |
| Michelle Mitchell | Director, Executive |
| Duane Mitchell | Director |
| Edgardo Rodriguez | Director, Executive |
| Edgardo Rodriguez Lebron | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2534 Sw 115th Drive
Gainesville, FL, 32608
Gainesville, FL, 32608